This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Non-Hodgkin's lymphoma of the stomach

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Non-Hodgkin's lymphoma is the commonest non-epithelial malignant neoplasm of the stomach, accounting for about 3% of all gastric neoplasms. Helicobacter pylori is associated with the development of gastric lymphoma.

Presentation is usually late. Symptoms are often non-specific for example anorexia and weight loss.

Contrast radiography may show anything from a large tumour mass to accentuated rugae.

Treatment is dependent upon staging:

  • if the tumour is confined to the stomach:
    • radical resection is indicated
    • this may be followed by radio- and chemotherapy
  • lymph node involvement:
    • radiotherapy and chemotherapy are indicated
  • low-grade primary gastric lymphomas may completely regress after eradication of H. pylori infection

The prognosis is better for gastric lymphoma - 40-50% five year survival compared to those sited more distally in the gastrointestinal tract.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.